
Charles River Laboratories
0.73 %
-46.54 %
Yet to be announced
Company Overview
Charles River Laboratories International, Inc. is a global provider of essential products and services to help pharmaceutical and biotechnology companies, government agencies, and academic institutions accelerate their research and drug development efforts. The company focuses on providing research models, discovery services, safety assessment services, and manufacturing support services.
Their main revenue streams come from laboratory testing services, research model sales, and contract research services for drug development - all of which are halal business activities as they contribute to medical research and healthcare advancement.
Revenue Sources
PassBased on the company's SEC filings and financial reports, Charles River Laboratories' revenue primarily comes from providing research services, laboratory testing, and research models for the pharmaceutical and biotechnology industry. None of these core business activities involve haram products or services.
Reliance on Interest
Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
Dec. 28, 2024 | $1.0b | $1.2b | - | $28.23m | 0.00% | 2.36% |
Sept. 28, 2024 | $1.01b | $922.64m | - | $30.28m | 0.00% | 3.28% |
June 29, 2024 | $1.03b | $907.23m | - | $32.77m | 0.00% | 3.61% |
March 30, 2024 | $1.01b | $920.58m | - | $35.0m | 0.00% | 3.80% |
Based on the financial data from the last four quarters, the company's interest expense to total expense ratios have been consistently below the 5% threshold that would indicate material reliance on interest. The company maintains a healthy operational profile where interest expenses are not a significant part of their business model.
Operational Ethics
PassAfter reviewing the company's operations and public disclosures, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company operates globally but maintains ethical standards in its operations and partnerships.
Comments